Compile Data Set for Download or QSAR
Report error Found 1957 for UniProtKB: Q02108
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213276(US9278968, 35)
Affinity DataEC50:  6.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213277(US9278968, 36)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213278(US9278968, 37)
Affinity DataEC50:  7.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213279(US9278968, 38)
Affinity DataEC50:  2.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213280(US9278968, 39)
Affinity DataEC50:  4.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213281(US9278968, 40)
Affinity DataEC50:  3.80E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213282(US9278968, 41)
Affinity DataEC50:  5.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213283(US9278968, 42)
Affinity DataEC50:  3.30E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213284(US9278968, 43)
Affinity DataEC50:  1.40E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213285(US9278968, 44)
Affinity DataEC50:  1.60E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213286(US9278968, 45)
Affinity DataEC50:  9.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213287(US9278968, 46)
Affinity DataEC50:  2.00E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213288(US9278968, 47)
Affinity DataEC50:  1.30E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213289(US9278968, 48)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213290(US9278968, 49)
Affinity DataEC50:  2.50E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213291(US9278968, 50)
Affinity DataEC50:  7.90E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213292(US9278968, 51)
Affinity DataEC50:  1.20E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213293(US9278968, 52)
Affinity DataEC50:  2.20E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213294(US9278968, 53)
Affinity DataEC50:  1.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213295(US9278968, 54)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213296(US9278968, 55)
Affinity DataEC50:  2.00E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213297(US9278968, 56)
Affinity DataEC50:  8.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213298(US9278968, 57)
Affinity DataEC50:  3.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213299(US9278968, 58)
Affinity DataEC50:  3.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213300(US9278968, 59)
Affinity DataEC50:  1.90E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213302(US9278968, 60)
Affinity DataEC50:  1.20E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213303(US9278968, 61)
Affinity DataEC50:  6.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213304(US9278968, 62)
Affinity DataEC50:  6.50E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213306(US9278968, 64)
Affinity DataEC50:  3.00E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213308(US9278968, 66)
Affinity DataEC50:  1.60E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213309(US9278968, 67)
Affinity DataEC50:  2.40E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213310(US9278968, 68)
Affinity DataEC50:  1.40E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213311(US9278968, 69)
Affinity DataEC50:  4.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213313(US9278968, 70)
Affinity DataEC50:  3.80E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213314(US9278968, 71)
Affinity DataEC50:  2.10E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213315(US9278968, 72)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213316(US9278968, 73a)
Affinity DataEC50:  6.40E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213318(US9278968, 74)
Affinity DataEC50:  1.20E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213319(US9278968, 75)
Affinity DataEC50:  9.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213320(US9278968, 76)
Affinity DataEC50:  5.80E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213321(US9278968, 77)
Affinity DataEC50:  1.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213322(US9278968, 78)
Affinity DataEC50:  5.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213324(US9278968, 80)
Affinity DataEC50:  7.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213327(US9278968, 83)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213328(US9278968, 84)
Affinity DataEC50:  7.10E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213329(US9278968, 85)
Affinity DataEC50:  2.90E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213330(US9278968, 86)
Affinity DataEC50:  5.60E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213331(US9278968, 87)
Affinity DataEC50:  5.90E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213332(US9278968, 88)
Affinity DataEC50:  5.30E+3nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandPNGBDBM213333(US9278968, 89)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:Using an sGCα 1 gene (NCBI accession No. BC028384.2) and an sGCβ1 gene (NCBI accession No. BC047620.1), an N-terminal FLAG tag-fused sGC&a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 1957 total ) | Next | Last >>
Jump to: